February 6, 2018 / 11:38 AM / 14 days ago

BRIEF-Haemonetics Corp Qtrly Revenue $234.0 Million

Feb 6 (Reuters) - Haemonetics Corp:

* QTRLY REVENUE OF $234.0 MILLION WAS UP 2.7 PCT‍​

* QTRLY ADJUSTED EARNINGS PER SHARE $0.62; QTRLY LOSS PER SHARE $0.12

* BOARD OF DIRECTORS AUTHORIZES $260 MILLION SHARE REPURCHASE PROGRAM‍​

* INCURRED $31.3 MILLION OF RESTRUCTURING AND TURNAROUND COSTS IN QUARTER

* SEES FISCAL 2018 GAAP EARNINGS PER SHARE $.80 - $.85

* SEES FISCAL 2018 ADJUSTED EARNINGS PER SHARE $1.80 - $1.90

* SEES FISCAL 2018 FREE CASH FLOW, BEFORE RESTRUCTURING & TURNAROUND OF ABOUT $125 MILLION

* SEES FISCAL 2018 CAPITAL EXPENDITURES $40 - 50 MILLION

* HAEMONETICS- COMPLEXITY REDUCTION INITIATIVE EXPECTED TO DELIVER $80 MILLION IN ANNUAL RUN RATE SAVINGS; SAVINGS ARE EXPECTED TO BE MINIMAL IN FISCAL 2018

* Q3 EARNINGS PER SHARE VIEW $0.44, REVENUE VIEW $227.6 MILLION -- THOMSON REUTERS I/B/E/S

* EXPECTS TO INCUR AGGREGATE RESTRUCTURING CHARGES OF $50-$60 MILLION TO COMPLETE COMPLEXITY REDUCTION INITIATIVE

* FY2018 EARNINGS PER SHARE VIEW $1.70 -- THOMSON REUTERS I/B/E/S Source text for Eikon: (bit.ly/2FRec83) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below